Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer. Issue 4 (1st April 2022)
- Record Type:
- Journal Article
- Title:
- Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer. Issue 4 (1st April 2022)
- Main Title:
- Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer
- Authors:
- Tang, Shi
Wen, Peiqi
Li, Kaiheng
Deng, Jiehua
Yang, Bo - Abstract:
- ABSTRACT: In the recent study, we have developed novel tumor targetable and pH-sensitive PLGA nanoparticles co-loaded with camptothecin (CPT) and metformin (Metf) to simultaneously improve the Type 2 Diabetes Mellitus (T2DM) and malignant breast cancer. To improve the drug loading efficiency, the hydrophobic CPT was conjugated with PLGA polymer by the pH-sensitive hydrazone bonds (hyd). Then, the Metf was physically loaded into the hydrophobicity inner core of CPT-conjugated PLGA nanocomplex to form the dual drugs-loaded nanoparticles (NP/CPT-Metf). Furthermore, on the surface of NP/CPT-Metf was modified with tumor-homing CGKRK peptides to obtain the tumor targetable and pH-sensitive polymer nanoparticles (CNP/CPT-Metf). It was demonstrated that the developed CNP/CPT-Metf displayed sufficient sensitivity to the weak acidic tumor microenvironment. Besides, excellent ability of CNP/CPT-Metf to mediate accumulation of drugs in cells and tumor tissues finally in turn resulted in a signal enhanced anti-tumor effect. Furthermore, it was demonstrated as well that CNP/CPT-Metf was able of significantly alleviating the type 2 diabetes mellitus in diabetic mice. In summary, the developed multifunctional polymer nanoparticles might represent a promising strategy for simultaneously improve the T2DM and treat malignant breast cancer. GRAPHICAL ABSTRACT: uf0001
- Is Part Of:
- Bioengineered. Volume 13:Issue 4(2022)
- Journal:
- Bioengineered
- Issue:
- Volume 13:Issue 4(2022)
- Issue Display:
- Volume 13, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 13
- Issue:
- 4
- Issue Sort Value:
- 2022-0013-0004-0000
- Page Start:
- 9754
- Page End:
- 9765
- Publication Date:
- 2022-04-01
- Subjects:
- Type 2 Diabetes Mellitus -- malignant breast cancer -- tumor targeting -- pH-sensitive -- nanoparticles
Biomedical engineering -- Periodicals
Biotechnology -- Periodicals
Microbiology -- Periodicals
660.6 - Journal URLs:
- http://www.tandfonline.com/toc/kbie20/current ↗
http://www.landesbioscience.com/journals/bioe/ ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/21655979.2022.2060721 ↗
- Languages:
- English
- ISSNs:
- 2165-5987
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21267.xml